Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, AntagomiR-based therapy for Ischemic heart disease: Expression of AntagomiR-23b in bone-derived marrow cells mediates cardiac repair after myocardial infarction via down regulation of its target gene, 19/February/2015, 22.48, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that AntagomiR-23b, by suppressing the expression of its target gene, it may promote cardiac repair after myocardial infarction. Thus, pharmacological formulations encompassing “AntagomiR-23b or inhibitors of miR-23b“ may be used to promote cardiac repair.
Amount: $ 300*
Undisclosed information: How miR-23b inhibits cardiac repair after myocardial infarction
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
